KDR and neoplasm: Their data emphasize a specific role of the B55α/PP2A phosphatase complex in tumor vascular remodeling and suggested the promising application values of PP2A-inhibitors as robust anti-angiogenic agents exclusively targeting nascent blood vessels with a mode-of-action complementary to anti-VEGFR therapies (179).